198 related articles for article (PubMed ID: 36151295)
1. Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70
de Vries HD; Palmiotti A; Li R; Hovingh MV; Mulder NL; Koehorst M; Bloks VW; van Zutphen T; Kuipers F; de Boer JF
Pediatr Res; 2023 May; 93(6):1582-1590. PubMed ID: 36151295
[TBL] [Abstract][Full Text] [Related]
2. Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid.
de Boer JF; de Vries HD; Palmiotti A; Li R; Doestzada M; Hoogerland JA; Fu J; La Rose AM; Westerterp M; Mulder NL; Hovingh MV; Koehorst M; Kloosterhuis NJ; Wolters JC; Bloks VW; Haas JT; Dombrowicz D; Staels B; van de Sluis B; Kuipers F
Cell Mol Gastroenterol Hepatol; 2021; 11(4):1045-1069. PubMed ID: 33309945
[TBL] [Abstract][Full Text] [Related]
3. Short-term obeticholic acid treatment does not impact cholangiopathy in Cyp2c70-deficient mice with a human-like bile acid composition.
Li R; Hovingh MV; Koehorst M; de Blaauw P; Verkade HJ; de Boer JF; Kuipers F
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Aug; 1867(8):159163. PubMed ID: 35470044
[TBL] [Abstract][Full Text] [Related]
4. Sex-, age-, and organ-dependent improvement of bile acid hydrophobicity by ursodeoxycholic acid treatment: A study using a mouse model with human-like bile acid composition.
Ueda H; Honda A; Miyazaki T; Morishita Y; Hirayama T; Iwamoto J; Nakamoto N; Ikegami T
PLoS One; 2022; 17(7):e0271308. PubMed ID: 35819971
[TBL] [Abstract][Full Text] [Related]
5. Absence of gut microbiota reduces neonatal survival and exacerbates liver disease in Cyp2c70-deficient mice with a human-like bile acid composition.
Sjöland W; Wahlström A; Makki K; Schöler M; Molinaro A; Olsson L; Greiner TU; Caesar R; de Boer JF; Kuipers F; Bäckhed F; Marschall HU
Clin Sci (Lond); 2023 Jul; 137(13):995-1011. PubMed ID: 37384590
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition.
Verkade E; Shen W; Hovingh MV; Mulder NL; de Bruyn K; Koehorst M; de Vries HD; Bloks VW; Kuipers F; de Boer JF
Clin Sci (Lond); 2023 Nov; 137(21):1637-1650. PubMed ID: 37910096
[TBL] [Abstract][Full Text] [Related]
8. Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice.
Hasan MN; Chen J; Matye D; Wang H; Luo W; Gu L; Clayton YD; Du Y; Li T
J Lipid Res; 2023 Mar; 64(3):100340. PubMed ID: 36737039
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
10. Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70
Li R; Palmiotti A; de Vries HD; Hovingh MV; Koehorst M; Mulder NL; Zhang Y; Kats K; Bloks VW; Fu J; Verkade HJ; de Boer JF; Kuipers F
J Lipid Res; 2021; 62():100134. PubMed ID: 34626589
[TBL] [Abstract][Full Text] [Related]
11. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
12. Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury.
Truong JK; Bennett AL; Klindt C; Donepudi AC; Malla SR; Pachura KJ; Zaufel A; Moustafa T; Dawson PA; Karpen SJ
J Lipid Res; 2022 Sep; 63(9):100261. PubMed ID: 35934110
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Purucker E; Marschall HU; Winograd R; Matern S
Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
[TBL] [Abstract][Full Text] [Related]
14. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
Macias RI; Jimenez S; Serrano MA; Monte MJ; Marin JJ
Life Sci; 2006 Aug; 79(10):1014-9. PubMed ID: 16764892
[TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
Cai SY; Mennone A; Soroka CJ; Boyer JL
J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
[TBL] [Abstract][Full Text] [Related]
18. Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in
Palmiotti A; de Vries HD; Hovingh MV; Koehorst M; Mulder NL; Verkade E; Veentjer MK; van Dijk TH; Bloks VW; Havinga R; Verkade HJ; de Boer JF; Kuipers F
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760936
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.
Thérien A; Cieślak A; Verreault M; Perreault M; Trottier J; Gobeil S; Vohl MC; Barbier O
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444777
[TBL] [Abstract][Full Text] [Related]
20. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
